Sphera Funds Management Ltd. Amicus Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

$545 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $4.69 Million - $8.37 Million	753,037 New	753,037 $8.09 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $4.82 Million - $6.11 Million	-491,159 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $4.29 Million - $5.82 Million	491,159 New	491,159 $4.69 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $2.44 Million - $6.34 Million	-265,753 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $13.2 Million - $24.3 Million	-977,797 Reduced 78.63%	265,753 $6.14 Million
Q3 2020 Nov 12, 2020	SELL	$12.89 - $15.89 $4.96 Million - $6.12 Million	-385,000 Reduced 23.64%	1,243,550 $17.6 Million
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $3.45 Million - $6.1 Million	-389,074 Reduced 19.28%	1,628,550 $24.6 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $5.19 Million - $8.73 Million	-782,696 Reduced 27.95%	2,017,624 $18.6 Million
Q4 2019 Feb 13, 2020	SELL	$7.48 - $10.75 $972,400 - $1.4 Million	-130,000 Reduced 4.44%	2,800,320 $27.3 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $3.37 Million - $5.57 Million	420,000 Added 16.73%	2,930,320 $23.5 Million
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $243,772 - $320,284	22,242 Added 0.89%	2,510,320 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $402,443 - $557,969	40,084 Added 1.64%	2,488,078 $33.8 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $5.53 Million - $8.87 Million	660,000 Added 36.91%	2,447,994 $23.5 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $6.95 Million - $9.91 Million	598,938 Added 50.37%	1,787,994 $21.6 Million
Q2 2018 Aug 13, 2018	SELL	$13.13 - $17.09 $8.62 Million - $11.2 Million	-656,648 Reduced 35.58%	1,189,056 $18.6 Million
Q1 2018 May 10, 2018	BUY	$13.76 - $17.12 $10.3 Million - $12.8 Million	745,704 Added 67.79%	1,845,704 $27.8 Million
Q4 2017 Feb 12, 2018	BUY	$12.51 - $16.24 $8.51 Million - $11 Million	680,000 Added 161.9%	1,100,000 $15.8 Million
Q3 2017 Nov 09, 2017	BUY	$11.74 - $15.78 $4.93 Million - $6.63 Million	420,000	420,000 $6.33 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$271 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$264 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$229 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$226 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$218 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Account